An experimental lung disease drug developed using artificial intelligence showed promise in reversing biological signs of aging, pointing to broader potential use of the treatment, according to its developer.
An experimental lung disease drug developed using artificial intelligence showed promise in reversing biological signs of aging, pointing to broader potential use of the treatment, according to its developer.
<iframe src="https://statesidedaily.com/embed/cluster/0b2291b5b3694a8d804614540e61a1daa707ec83" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="AI-Discovered Drug Reverses Aging Markers in Study, Biotech Says"></iframe>
